Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

Major Events: 2/1 Ino-4800 Completed P2 Enrollment. 2/2 4:50P ET JK’s Ino-4800 Update at NY Academy of Sciences. 3/8 KB, TMO at 2ND ANNUAL EUROPEAN HEALTHTECH CEO FORUM

1. INOVIO Completes Enrollment in Phase 2 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in early March, Submitted to FDA in March

2. The Quest for a COVID-19 Vaccine
Tuesday, February 2, 2021, 10:00 AM - Wednesday, February 3, 2021, 5:35 PM EST

Presented By
Microbiology and Infectious Diseases Discussion Group
The New York Academy of Sciences

Tuesday
February 02, 2021

10:15 AM
KEYNOTE ADDRESS
Speakers
Moncef Slaoui, PhD
Operation Warp Speed

Keynote Chair: Stanley Plotkin, MD
University of Pennsylvania

11:00 AM
KEYNOTE ADDRESS: The Year in Review: A Vaccinologist’s Perspective
Speakers
Anthony S. Fauci, MD
National Institute of Allergy and Infectious Diseases (NIAID), NIH

Keynote Chair: Nicholas B. Dirks, PhD
New York Academy of Sciences

SESSION III: Efficacy Studies, Part 1
Session Chairperson
Annaliesa Anderson, PhD, Pfizer
2:50 PM
Efficacy Data Updates from Moderna’s mRNA Vaccine Candidate
Speaker
Tal Zaks, MD, PhD
Moderna
3:20 PM
Efficacy Data Updates from Pfizer’s mRNA Vaccine Candidate
Speaker
Kathrin Jansen, PhD
Pfizer
3:50 PM
Break
4:00 PM
Efficacy Data Updates from Novavax’s Protein-based Vaccine Candidate
Speaker
Gregory Glenn, MD
Novavax
SESSION IV: Update Talks
Session Chairperson
Emmanuel Hanon, PhD, GlaxoSmithKline
4:30 PM
Updates from Codagenix’s Vaccine Candidate
Speaker
J. Robert Coleman, PhD, MBA
Codagenix
4:50 PM
Updates from Inovio Pharmaceutical’s DNA Vaccine Candidate
Speaker
J. Joseph Kim, MBA, PhD
Inovio Pharmaceuticals
SESSION V: Day 1 Closing Talk
Session Chairperson
Stanley Plotkin, MD, University of Pennsylvania
5:10 PM
The Role of Modern Vaccinology in Responding to New Epidemics
Speaker
John R. Mascola, MD
National Institute of Allergy and Infectious Diseases, NIH

https://www.nyas.org/events/2021/webinar-the-quest-for-a-covid-19-vaccine/

3. KB, TMO, Raghuram Selvaraju HCW speak at 2ND ANNUAL EUROPEAN HEALTHTECH CEO FORUM
FOR PARTNERING & INVESTMENT
8TH-9TH MARCH 2021 | DIGITAL CONFERENCE

HealthTech Innovation Day (Monday, 8th of March)
Digital Healthcare in the New Era of COVID-19 Panel
Digital Pharma & Drug Discovery Panel
MedTech & Device BD and Investment Panel
Revolutionising Hospital Care: New Technologies Panel
Innovation in Care Technology Panel
Innovation & Early Stage Investment Roundtable

Pandemic Response Day (Tuesday, 9th of March)
The Global Supply Chain in the Time of COVID-19 Panel
Overview of Vaccine Development & Roll Out Panel
Advanced Therapeutics Panel
Diagnostics: New Technologies Panel
Patient Care in the Time of the Pandemic Panel

Networking Days (10th - 12th of March)
Confirmed Keynote Speakers Include:

Introductory Speech by Jeffrey Cohen, Managing Director, Equity Research, Ladenburg Thalmann & Co. Inc.

Mark Stevenson, Executive Vice President & Chief Operating Officer, Thermo Fisher Scientific

Fireside Chat with Sean Marett, Chief Business Officer & Chief Commercial Officer, BioNTech SE

Confirmed Speakers Include:

Kate Broderick, Senior Vice President, Preclinical R&D, INOVIO Pharmaceuticals, Inc.

Raghuram Selvaraju, Chairman of the Board, Relief Therapeutics Holding AG and Managing Director, H.C. Wainwright & Co., LLC

https://www.sachsforum.com/2ehtf-about.html